Katsuhito Hashidzume
President chez HUMAN METABOLOME TECHNOLOGIES, INC.
Fortune : 30 485 $ au 31/03/2024
Profil
Katsuhito Hashidzume currently works at Human Metabolome Technologies, Inc., as President & Representative Director from 2019, HMT Biomedical KK, as President & Representative Director from 2018, and Mediome KK, as Non-Executive Director from 2018.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 7 044 ( 0,12% ) | 30 485 $ | 31/03/2024 |
Postes actifs de Katsuhito Hashidzume
| Sociétés | Poste | Début |
|---|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | President | 21/09/2019 |
HMT Biomedical KK
 HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | President | 01/12/2018 |
| Mediome KK | Director/Board Member | 01/12/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
HMT Biomedical KK
HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | Health Technology |
| Mediome KK |
